Get started

Avadel Pharmaceuticals plc

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

AVDL chart

Key stats

Market capitalization
980.337MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.33USD

About Avadel Pharmaceuticals plc

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gregory J. Divis
Website
avadel.com
Headquarters
Dublin
Employees
41
Founded
1990
ISIN
US05337M1045

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on the approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded in 1990 and is headquartered in Dublin, Ireland.

Ideas

AVDL hedged options strategyDublin-headquartered biopharmaceutical company Avadel Pharmaceuticals currently has a buzzy formulation of sodium oxybate in a Phase 3 clinical trial for the treatment of narcolepsy, among other candidates. The current twice-nightly U.S. narcolepsy oxybate market is estimated at $1.8 billion -- up t
Long
AVDL pre-PDUFA run up entryAvadel Pharmaceuticals is a biotech company which is currently anticipating approval for FT218, a drug treating narcolepsy. Im not gonna go in depth on it cuz it really doesn’t matter for the swing I'm tryna do, but basically breakthrough therapies like FT218 are highly demanded by investors. Thus,
Long
AVDL: Breakout Confirmed, 23.89% Potential Profit!Description: AVDL is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position. Stats: 1. Ideal buy range: $8 - $8.4 2. Take profit: $10.01 3. S
Long
$AVDL can fall in the next daysContextual immersion trading strategy idea. Avadel Pharmaceuticals operates as a specialty pharmaceutical company in the United States, France, and Ireland. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price in the next
Avadel Pharmaceuticals Announces Positive Topline Results from iAVDL: Avadel Pharmaceuticals plc 2020-04-27 07:00:10 Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
Long
Big Decisions with AVDL Next WeekFor the past year we can see that the market was not taking any price above 3.59. It mostly stayed between a range of 1.7 to 3.59. But recently the chart broke out on 9/19-9/23 and then started to fall back to its original range. the next couple weeks show promising strong movement. If it falls back
RISKY AVDL LOOKS TASTY R:R IS SAVAGEAvadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland. SHORT INTEREST 6.53M 07/31/19 P/E Current -0.85 P/E Ratio (with e
Long
1

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.43Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.36Fabulous
Learn more
FOREX.com
FOREX.com
Forex
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more